Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,160 | 127 | 95.6% |
| Education | $99.00 | 1 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $384.92 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $354.47 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $318.71 | 17 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $316.13 | 24 | $0 (2024) |
| Celgene Corporation | $101.60 | 5 | $0 (2024) |
| GENZYME CORPORATION | $80.89 | 4 | $0 (2024) |
| PFIZER INC. | $68.12 | 4 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $66.58 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $57.89 | 4 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $53.65 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $534.55 | 24 | Janssen Biotech, Inc. ($157.39) |
| 2023 | $792.55 | 48 | Takeda Pharmaceuticals U.S.A., Inc. ($176.14) |
| 2022 | $574.28 | 40 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($200.58) |
| 2021 | $241.31 | 14 | AbbVie Inc. ($57.12) |
| 2019 | $16.84 | 1 | ERBE USA Inc ($16.84) |
| 2018 | $99.00 | 1 | Janssen Biotech, Inc. ($99.00) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Gastroenterology | ||||||
| 03/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Immunology | ||||||
| 03/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Immunology | ||||||
| 03/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Immunology | ||||||
| 03/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Immunology | ||||||
| 02/16/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.39 | General |
| Category: Neuroscience | ||||||
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/14/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Immunology | ||||||
| 02/02/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $37.05 | General |
| Category: Immunology | ||||||
| 01/31/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Immunology | ||||||
| 01/24/2024 | Digestive Care, Inc. | Pertzye (Drug), Pertzye, Pertzye | Food and Beverage | Cash or cash equivalent | $32.36 | General |
| Category: Gastroenterology | ||||||
| 01/23/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Immunology | ||||||
| 01/22/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: Immunology | ||||||
| 01/17/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Immunology | ||||||
| 01/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Immunology | ||||||
| 01/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/22/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 473 | 503 | $230,514 | $47,274 |
| 2022 | 10 | 274 | 292 | $109,967 | $28,347 |
| 2021 | 3 | 79 | 85 | $20,435 | $9,018 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 56 | 56 | $59,710 | $7,572 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 52 | $14,110 | $5,473 | 38.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 44 | $12,447 | $4,643 | 37.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 58 | 59 | $46,830 | $4,574 | 9.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 19 | 19 | $22,795 | $3,983 | 17.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $11,390 | $3,833 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 53 | $10,135 | $3,717 | 36.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 53 | $8,153 | $3,467 | 42.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $9,822 | $2,263 | 23.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $13,243 | $2,003 | 15.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 52 | 54 | $6,740 | $1,702 | 25.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 12 | 13 | $5,811 | $1,288 | 22.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $4,723 | $1,010 | 21.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $1,650 | $747.56 | 45.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 13 | $1,105 | $527.15 | 47.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,850 | $469.98 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 72 | $13,560 | $5,437 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 45 | $10,645 | $4,466 | 42.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $22,792 | $2,856 | 12.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 25 | $7,299 | $2,816 | 38.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $7,112 | $2,715 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,150 | $2,464 | 34.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $21,705 | $2,346 | 10.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 33 | $5,115 | $1,899 | 37.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $4,705 | $1,821 | 38.7% |
About Dr. Shyam Patel, MD
Dr. Shyam Patel, MD is a Gastroenterology healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2014. The National Provider Identifier (NPI) number assigned to this provider is 1124439427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shyam Patel, MD has received a total of $2,259 in payments from pharmaceutical and medical device companies, with $534.55 received in 2024. These payments were reported across 128 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,160).
As a Medicare-enrolled provider, Patel has provided services to 826 Medicare beneficiaries, totaling 880 services with total Medicare billing of $84,639. Data is available for 3 years (2021–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Voorhees, NJ
- Active Since 05/08/2014
- Last Updated 06/30/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124439427
Products in Payments
- ENTYVIO (Biological) $287.64
- TRULANCE (Drug) $191.36
- STELARA (Biological) $190.63
- DUPIXENT (Biological) $134.54
- REMICADE (Biological) $130.34
- XIFAXAN (Drug) $124.77
- LINZESS (Drug) $109.56
- ZEPOSIA (Drug) $101.60
- VIBERZI (Drug) $91.48
- XELJANZ (Drug) $68.12
- Linzess (Drug) $66.58
- CREON (Drug) $58.34
- DIFICID (Drug) $57.89
- RINVOQ (Biological) $54.94
- IDACIO (Biological) $48.70
- OMVOH (Drug) $45.00
- ZENPEP (Drug) $44.78
- CIMZIA (Drug) $41.80
- IBSRELA (Drug) $41.08
- HUMIRA (Biological) $36.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Voorhees
Dr. Sanket Patel, D.o, D.O
Gastroenterology — Payments: $39,650
Dr. Alan Mushnick, Md, MD
Gastroenterology — Payments: $26,516
Elizabeth Egan, Md, MD
Gastroenterology — Payments: $10,600
Dr. Michael Goldstein, Md, MD
Gastroenterology — Payments: $10,508
Alex Celluzzi, Do, DO
Gastroenterology — Payments: $9,192
Andrew Alloy, Do, DO
Gastroenterology — Payments: $9,041